These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9059966)

  • 21. Mesalazine-induced lung fibrosis.
    Alskaf E; Aljoudeh A; Edenborough F
    BMJ Case Rep; 2013 Apr; 2013():. PubMed ID: 23576654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mesalazine tolerance in patients with inflammatory bowel disease and previous intolerance or allergy to sulphasalazine or sulphonamides.
    Turunen U; Elomaa I; Anttila VJ; Seppälä K
    Scand J Gastroenterol; 1987 Sep; 22(7):798-802. PubMed ID: 2890198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mesalamine-induced hypersensitivity pneumonitis. A case report and review of the literature.
    Sviri S; Gafanovich I; Kramer MR; Tsvang E; Ben-Chetrit E
    J Clin Gastroenterol; 1997 Jan; 24(1):34-6. PubMed ID: 9013348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug insight: aminosalicylates for the treatment of IBD.
    Nielsen OH; Munck LK
    Nat Clin Pract Gastroenterol Hepatol; 2007 Mar; 4(3):160-70. PubMed ID: 17339853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mesalazine-associated tubulo-interstitial nephritis in inflammatory bowel disease.
    Calviño J; Romero R; Pintos E; Losada E; Novoa D; Güimil D; Mardaras J; Sanchez-Guisande D
    Clin Nephrol; 1998 Apr; 49(4):265-7. PubMed ID: 9582560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mesalazine].
    Engelhardt K; Mohr K
    Dtsch Med Wochenschr; 1995 May; 120(21):769-70. PubMed ID: 7781502
    [No Abstract]   [Full Text] [Related]  

  • 27. [5-aminosalicylic acid and chronic inflammatory bowel diseases in children].
    Klotz U
    Klin Padiatr; 1995; 207(5):285-7. PubMed ID: 7500605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pancreatitis in a patient with Crohn disease treated with mesalazine and azathioprine].
    Glintborg B
    Ugeskr Laeger; 2000 Aug; 162(34):4553-4. PubMed ID: 10981226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical pharmacokinetics of slow release mesalazine.
    De Vos M
    Clin Pharmacokinet; 2000 Aug; 39(2):85-97. PubMed ID: 10976656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Drug therapy of chronic inflammatory bowel disease--reliable standards and new developments].
    Fischbach W
    Leber Magen Darm; 1992 Mar; 22(2):49-55. PubMed ID: 1350043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesalazine: a global safety evaluation.
    Brimblecombe R
    Scand J Gastroenterol Suppl; 1990; 172():66. PubMed ID: 1972297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk-benefit assessment of drugs used in the treatment of inflammatory bowel disease.
    Hanauer SB; Stathopoulos G
    Drug Saf; 1991; 6(3):192-219. PubMed ID: 1676590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kawasaki-like syndrome after treatment with mesalazine.
    Waanders H; Thompson J
    Am J Gastroenterol; 1991 Feb; 86(2):219-21. PubMed ID: 1992637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systematic review: the use of mesalazine in inflammatory bowel disease.
    Bergman R; Parkes M
    Aliment Pharmacol Ther; 2006 Apr; 23(7):841-55. PubMed ID: 16573787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leukocyte-endothelial cell interactions: potential targets for mesalazine in Crohn's disease.
    Wakefield AJ; Hudson M; Pounder RE
    Adv Exp Med Biol; 1995; 371B():1307-11. PubMed ID: 7502806
    [No Abstract]   [Full Text] [Related]  

  • 36. Mesalazine (5-aminosalicylic acid) induced chronic hepatitis.
    Deltenre P; Berson A; Marcellin P; Degott C; Biour M; Pessayre D
    Gut; 1999 Jun; 44(6):886-8. PubMed ID: 10323894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mesalamine capsules for the treatment of active Crohn's disease: results of a 16-week trial. Pentasa Crohn's Disease Study Group.
    Singleton JW; Hanauer SB; Gitnick GL; Peppercorn MA; Robinson MG; Wruble LD; Krawitt EL
    Gastroenterology; 1993 May; 104(5):1293-301. PubMed ID: 8482443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pericarditis associated with longstanding mesalazine administration in a patient.
    Vayre F; Vayre-Oundjian L; Monsuez JJ
    Int J Cardiol; 1999 Feb; 68(2):243-5. PubMed ID: 10189017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A controlled double blind multicenter study of the effectiveness of 5-aminosalicylic acid in patients with Crohn's disease in remission.
    Arber N; Odes HS; Fireman Z; Lavie A; Broide E; Bujanover Y; Becker S; Pomerantz I; Moshkowitz M; Patz J
    J Clin Gastroenterol; 1995 Apr; 20(3):203-6. PubMed ID: 7797827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Mesalazine-related interstitial lung disease: an under-diagnosed effect?].
    Auffret M; Béné J; Lambert M; Gautier S
    Therapie; 2014; 69(6):531-2. PubMed ID: 25320942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.